Feasibility Study for VCool™ Intranasal Cooling System in Healthy Volunteers

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorNeuroIntact Inc.

About this trial

The objective of this study is to evaluate the performance and safety of the VCool Intranasal Cooling System in healthy adult volunteers. The study is designed to gather preliminary data regarding air flow rates and time required to reduce core body temperature to 35.5℃ and maintain the temperature between 35℃ and 36℃ for one hour after cooling.

Eligibility criteria

Qualifiers

Male or female ages 18 to 55.

An Institutional Review Board (IRB) approved informed consent is signed and dated prior to any study-related activities.

Baseline core body temperature between 36.8℃ and 37.5℃.

Have the ability to understand the requirements of the study and are willing to comply with all study procedures.

Disqualifiers

History of cardiovascular, respiratory, or metabolic disorder

Any contraindication to undergoing Magnetic Resonance Imaging (MRI)

Pregnant

Severe peripheral vascular disease

Trial design

Treatments tested in this trial

  • Targeted Temperature Management Intranasal Cooling System

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators

NeuroIntact Inc.

Lead sponsor

University of Maryland, Baltimore

Collaborator

United States Department of Defense

Collaborator